Mental health
New drugs
On this page:
APO-Desvenlafaxine
Medical ingredient:
Desvenlafaxine
Indication:
APO-Desvenlafaxine has been prescribed to you by your doctor to treat your depression.
Foquest
Medical ingredient:
Methylphenidate Hydrochloride
Indication:
Foquest is used in adults to treat Attention Deficit Hyperactivity Disorder (ADHD).
pms-Fluoxetine
Medical ingredient:
Fluoxetine Hydrochloride
Indication:
pms-Fluoxetine has been prescribed by your doctor to relieve your symptoms of:
- Depression (feeling sad, a change in appetite or weight, difficulty concentrating or sleeping, feeling tired, headaches, unexplained aches and pain)
- Bulimia (eating disorder, characterized by self-induced vomiting after eating)
- Obsessive-Compulsive disorder (recurrent and intrusive thought, feeling, idea, or sensation; recurrent pattern of behaviour, or unwanted thoughts or actions)
Rexulti
(new active substance)
Medical ingredient:
Brexpiprazole
Indication:
Rexulti is used for the treatment of schizophrenia in adults.
For more information, see the Regulatory Decision Summary.
New generic drugs
Health Canada approved three new generic drugs for mental health.
Risk communications
Health Canada released three risk communications for mental health.